Explore more publications!

Press Releases

France Reports Third Infant Death Linked to Baby Formula

France Reports Third Infant Death Linked to Baby Formula

France Reports Third Infant Death Amid Baby Formula Recalls

France Reports Third Infant Death Amid Baby Formula Recalls

Recruiting for Good Launch Sweet B-Day Gift Celebrate Valentine's Day in Paris
Understand Tech Launches AI-In-a-Box, an Integrated On-Premise Enterprise AI Appliance
Azilen Technologies Partners with OroCommerce to Deliver Scalable, Intelligent B2B Commerce Solutions
Abaxx Broadens European Wind Futures Coverage with Enwex Netherlands, France and Spain Futures Contracts
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
ProLogium Breaks Ground on Dunkirk Gigafactory in France
Myseum Highlights Monetization Strategy, Influencer Platform and New Safe Social Media Technology in Letter to Shareholders
ArcelorMittal confirms the construction of an electric arc furnace in Dunkirk, France: a €1.3 billion investment supporting an important step in its decarbonisation
Tissue and Regenerative Engineering Market Company, Government & Public Sector Funding Data
Agricultural Sprayers Market Projected to Reach US$ 4.6 Bn by 2032, Persistence Market Research
France Emerges as Europe’s Top Strategic Hub for Investors, Talent and Property Buyers in 2026
France First EU Nation to Open Consulate General in Greenland

France First EU Nation to Open Consulate General in Greenland

France Establishes First EU Consulate in Greenland

France Establishes First EU Consulate in Greenland

France Opens First EU Consulate General in Greenland

France Opens First EU Consulate General in Greenland

France Opens First EU Consulate in Greenland

France Opens First EU Consulate in Greenland

DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors
TSplus Promotes Thomas Montalcino to Chief Technology Officer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions